Diabetes and cancer: 5 years into the recent controversy

European Journal of Cancer

Volumn 50, Issue 12, 2014, Pages 2119-2125

  Badrick, Ellena ^a   Renehan, Andrew G ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Diabetes; Immortal time bias; Incidence risk; Insulin; Metformin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN DERIVATIVE; METFORMIN; PIOGLITAZONE;

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; COMMUNITY; DIABETES MELLITUS; HUMAN; NEOPLASM; OBSERVATIONAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL;

CANCER; DIABETES; IMMORTAL TIME BIAS; INCIDENCE RISK; INSULIN; METFORMIN;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; NEOPLASMS; RISK FACTORS;

EID: 84904036821     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.04.032     Document Type: Article

References (40)

1. IDF. International Diabetes Federation, Diabetes Atlas, 6th ed. http://www.idf.org/diabetesatlas/europe [accessed 17 Feb 2014].
2. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, and H. Comber et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 6 2013 1374 1403
3. L.V. van de Poll-Franse, S. Houterman, M.L. Janssen-Heijnen, M.W. Dercksen, J.W. Coebergh, and H.R. Haak Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis Int J Cancer 120 9 2007 1986 1992
4. M. Greenwood, and F. Wood The Relation between the Cancer and Diabetes Death-rates J Hyg (Lond) 14 1 1914 83 118
5. H.M. Colhoun Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 9 2009 1755 1765
6. C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 9 2009 1766 1777
7. L.G. Hemkens, U. Grouven, R. Bender, C. Gunster, S. Gutschmidt, and G.W. Selke et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 9 2009 1732 1744
8. J.M. Jonasson, R. Ljung, M. Talback, B. Haglund, S. Gudbjornsdottir, and G. Steineck Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 9 2009 1745 1754
9. U. Smith, and E.A. Gale Does diabetes therapy influence the risk of cancer? Diabetologia 52 9 2009 1699 1708
10. A.G. Renehan Insulin analogues and cancer risk: the emergence of second-generation studies Diabetologia 55 1 2012 7 9
11. U. Smith, and E.A. Gale Cancer and diabetes: are we ready for prime time? Diabetologia 53 8 2010 1541 1544
12. E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergenstal, S.M. Gapstur, and L.A. Habel et al. Diabetes and cancer: a consensus report Diabetes Care 33 7 2010 1674 1685
13. A. Renehan, U. Smith, and M.S. Kirkman Linking diabetes and cancer: a consensus on its complexity [commentary] Lancet 375 9733 2010 2201 2202
14. J.A. Johnson, B. Carstensen, D. Witte, S.L. Bowker, L. Lipscombe, and A.G. Renehan Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence Diabetologia 55 6 2012 1607 1618
15. A.G. Renehan, H.C. Yeh, J.A. Johnson, S.H. Wild, E.A. Gale, and H. Moller Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer Diabetologia 55 6 2012 1619 1632
16. J.J. Walker, J.A. Johnson, and S.H. Wild Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure Lancet Diab Endocrinol 1 2 2013 132 139
17. Y.B. Chen, Q. Chen, Z. Wang, and J. Zhou Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies PLoS One 8 11 2013 e81594
18. I.N. Colmers, S.L. Bowker, L.A. Tjosvold, and J.A. Johnson Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies Diabetes Metab 38 6 2012 485 506
19. X. Du, R. Zhang, Y. Xue, D. Li, J. Cai, and S. Zhou et al. Insulin glargine and risk of cancer: a meta-analysis Int J Biol Markers 27 3 2012 e241 246
20. M. Janghorbani, M. Dehghani, and M. Salehi-Marzijarani Systematic review and meta-analysis of insulin therapy and risk of cancer Horm Cancer 3 4 2012 137 146
21. O. Karlstad, J. Starup-Linde, P. Vestergaard, V. Hjellvik, M.T. Bazelier, and M.K. Schmidt et al. Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies Curr Drug Saf 8 5 2013 333 348
22. X. Tang, L. Yang, Z. He, and J. Liu Insulin glargine and cancer risk in patients with diabetes: a meta-analysis PLoS One 7 12 2012 e51814
23. H.C. Gerstein, J. Bosch, G.R. Dagenais, R. Diaz, H. Jung, and A.P. Maggioni et al. Basal insulin and cardiovascular and other outcomes in dysglycemia N Engl J Med 367 4 2012 319 328
24. D.R. Owens Glargine and cancer: can we now suggest closure? Diabetes Care 35 12 2012 2426 2428
25. Willey J. Diabetes pill beats cancer.and costs just 2p a day. Express http://www.express.co.uk/news/uk/384682/Diabetes-pill-beats-cancer-and-costs- just-2p-a-day [accessed 10 Feb 2014]. 2013.
26. S. Suissa, and L. Azoulay Metformin and the risk of cancer: time-related biases in observational studies Diabetes Care 35 12 2012 2665 2673
27. P.J. Goodwin, V. Stambolic, J. Lemieux, B.E. Chen, W.R. Parulekar, and K.A. Gelmon et al. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents Breast Cancer Res Treat 126 1 2011 215 220
28. R.J. Dowling, S. Niraula, V. Stambolic, and P.J. Goodwin Metformin in cancer: translational challenges J Mol Endocrinol 48 3 2012 R31 43
29. L. Azoulay, H. Yin, K.B. Filion, J. Assayag, A. Majdan, and M.N. Pollak et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study BMJ 344 2012 e3645
30. A. Neumann, A. Weill, P. Ricordeau, J.P. Fagot, F. Alla, and H. Allemand Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study Diabetologia 55 7 2012 1953 1962
31. J.D. Lewis, A. Ferrara, T. Peng, M. Hedderson, W.B. Bilker, and C.P. Quesenberry et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 4 2011 916 922
32. T. Wang, G. Ning, and Z. Bloomgarden Diabetes and cancer relationships J Diabetes 5 4 2013 378 390
33. P. Dolin Pioglitazone, bladder cancer, and detection bias J Diabetes 6 2 2014 193 194
34. P.C. Butler, M. Elashoff, R. Elashoff, and E.A. Gale A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 36 7 2013 2118 2125
35. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies The Lancet 371 9612 2008 569 578
36. M.R. Carnethon, P.J. De Chavez, M.L. Biggs, C.E. Lewis, J.S. Pankow, and A.G. Bertoni et al. Association of weight status with mortality in adults with incident diabetes JAMA 308 6 2012 581 590
37. J. Logue, J.J. Walker, G. Leese, R. Lindsay, J. McKnight, and A. Morris et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality Diabetes Care 36 4 2013 887 893
38. D.K. Tobias, A. Pan, C.L. Jackson, E.J. O'Reilly, E.L. Ding, and W.C. Willett et al. Body-mass index and mortality among adults with incident type 2 diabetes N Engl J Med 370 3 2014 233 244
39. L.L. Lipscombe, J.E. Hux, and G.L. Booth Reduced screening mammography among women with diabetes Arch Intern Med 165 18 2005 2090 2095
40. M.M. Zanders, L.N. van Steenbergen, H.R. Haak, H.J. Rutten, J.F. Pruijt, and P.M. Poortmans et al. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study Diabet Med 30 10 2013 1181 1188